Chronic obstructive pulmonary disease (COPD) is one of the leading global causes of
morbidity and mortality. A hallmark of COPD is progressive airflow obstruction primarily …

The heterogeneity of chronic obstructive pulmonary disease (COPD) creates many
diagnostic, prognostic, treatment and management challenges, as the pathogenesis of …

Аннотация В настоящее время хроническая обструктивная болезнь легких (ХОБЛ)
является глобальной проблемой и одной из ведущих причин смерти в мире. Терапия …

In this guideline update, we highlight important and new findings related to pharmacological
therapy of chronic obstructive pulmonary disease (COPD) that should change clinical …

Currently, chronic obstructive pulmonary disease (COPD) is a global health issue and one of
the leading causes of death in the world. COPD therapy includes pharmacological and non …

Chronic obstructive pulmonary disease patient care must include confirming a diagnosis
with postbronchodilator spirometry. Because of the clinical heterogeneity and the reality that …

Observational studies indicate that overutilization of inhaled corticosteroids (ICS) is common
in patients with chronic obstructive pulmonary disease (COPD). Overprescription and the …

Although nanoscaled metal–organic frameworks (nanoMOFs) are promising drug carriers,
their appropriate formulation remains almost unexplored and basically restricted to …

Background: Triple fixed-dose combination (FDC) therapy is recommended in severe
chronic obstructive pulmonary disease (COPD) patients experiencing frequent …

Аннотация Хроническая обструктивная болезнь легких (ХОБЛ) является
прогрессирующим заболеванием. При каждом обострении ухудшается прогноз …